Hemo Organic Stock Screener | Share Price & Fundamental Analysis
HEMORGANIC
Trading & Distributors
Screen Hemo Organic share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹18.21
▲
0.35 (1.96%)
Market Cap
₹6.75 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
-26.78
EPS (TTM)
₹0.47
Dividend Yield
-
Debt to Equity
-
52W High
₹21.44
52W Low
₹8.06
Operating Margin
2.00%
Profit Margin
-
Revenue (TTM)
₹3.00
EBITDA
-
Net Income
-
Total Assets
₹5.00
Total Equity
-
Hemo Organic Share Price History - Stock Screener Chart
Screen HEMORGANIC historical share price movements with interactive charts. Analyze price trends and patterns.
Hemo Organic Company Profile - Fundamental Screener
Screen Hemo Organic company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HEMORGANIC shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE422G01015
Hemo Organic Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen HEMORGANIC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 5 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Current Assets | 5 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 5 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Current Liabilities | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Reserves & Surplus | -4 | -4 | -4 | -4 | -3 | -3 | -3 | -3 | -3 | -3 |
Screen HEMORGANIC income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Expenses | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 2.00% | -2.00% | -1099.00% | -1138.00% | -912.00% | -593.00% | -8.00% | -220.00% | -170.00% | -13.00% | -50.00% | -38.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| EPS | 0.40 | 0.47 | -0.76 | -0.16 | -0.18 | -0.14 | -0.06 | -0.35 | -0.43 | -0.23 | -2.42 | -0.31 |
Hemo Organic Cash Flow Screener - Liquidity Fundamentals
Screen HEMORGANIC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Financing Activities | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen HEMORGANIC shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 16.85% | 16.85% | 16.85% | 16.85% | 16.85% | 16.85% | 16.85% | 16.85% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 71.11% | 70.66% | 70.64% | 73.58% | 72.22% | 72.05% | 70.99% | 74.14% |
| Other Holding | 12.04% | 12.49% | 12.51% | 9.57% | 10.94% | 11.10% | 12.16% | 9.01% |
| Shareholder Count | 5,218 | 5,212 | 5,213 | 5,178 | 4,902 | 4,774 | 5,048 | 5,677 |
Hemo Organic Dividend Screener - Share Yield Analysis
Screen HEMORGANIC dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Hemo Organic Index Membership - Market Screener Classification
Screen HEMORGANIC by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Hemo Organic Market Events Screener - Corporate Actions
Screen HEMORGANIC market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 11.58% | ||
| Annual General Meeting | NA | 19.11% | ||
| 2026-01-07 | 2026-01-07 | Extraordinary General Meeting | NA | 27.23% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 15.73% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.70% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 3.30% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | -2.82% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -14.15% |
Hemo Organic Competitors Screener - Peer Comparison
Screen HEMORGANIC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,487 | 11.17 | 99,562 | 11.11% | 1,821 | 47.63 |
| Elitecon International | 17,352 | 74.19 | 551 | 55040.00% | 70 | 45.97 |
| MMTC | 8,472 | 37.59 | 263 | 28.63% | 87 | 42.29 |
| BN Agrochem | 3,676 | 55.03 | 367 | 5071.83% | 20 | 50.10 |
| MSTC | 3,361 | 7.89 | 388 | -25.38% | 407 | 46.44 |
| Ravindra Energy | 2,966 | 42.96 | 262 | 79.10% | 23 | 57.50 |
| TCC Concept | 2,040 | 45.22 | 90 | 14.72% | 42 | 36.38 |
| Vintage Coffee & Beverages | 2,028 | 37.69 | 313 | 136.92% | 40 | 42.32 |
| RRP Defense | 1,259 | 506.53 | 11 | -16.00% | 1 | 70.39 |
| Creative Newtech | 1,111 | 18.58 | 1,802 | 3.48% | 53 | 56.62 |
Hemo Organic Company Announcements - News Screener
Screen HEMORGANIC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-03 | Notice Of Extra-Ordinary General Meeting (EGM) Of The Company | View |
| 2026-01-03 | Notice Of Extra-Ordinary General Meeting (EGM) Of The Company | View |
| 2025-12-11 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 11Th December 2025. | View |
| 2025-12-08 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 11Th December 2025. | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Un-Audited Financial Results Along With Limited Review Report Thereon For The Quarter And Half Year Ended On 30Th September 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday 14Th November 2025 | View |
| 2025-11-11 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday 14Th November 2025. | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Voting Results For AGM | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-05 | Intimation Of Book Closure & Cut-Off Date For Annual General Meeting | View |
| 2025-09-05 | Submission Of Annual Report For Financial Year 2024-25 | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-08-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Revision Of The Outcome Of The Board Meeting Dated 13.08.2025 | View |